Atlas Trials

Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma

Clinical trial NCT05736991 · UNKNOWN

Trial details

NCT number
NCT05736991
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung AdenocarcinomaRadiomicsGrading System
Start date
2022-11-01
Primary completion
2023-04-30
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.